Parkwalk closes PhoreMost follow-on investment
We are pleased to announce that Parkwalk has made an investment in Phoremost, a Cambridge University spinout, as part of a Series ‘B’ round of equity funding, alongside Amadeus Capital Partners and the University. Phoremost’s mission is to accelerate,… Read More
8power – Joins the LoRa Alliance™
8power is pleased to announce membership of the LoRa Alliance™, a global industry group to promote the development and deployment of the LoRaWAN™ Low Power Wide Area Network (LPWAN) open standard. The Alliance represents many of the leading… Read More
Sphere Fluidics – Parkwalk closes further funding round
We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously. Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D… Read More
Cytora – Parkwalk closes follow-on Investment
We are pleased to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund have closed an investment into Cytora, a geopolitical risk analytics spin-out from the University of Cambridge. Cytora is a pioneer in… Read More
Cambridge Touch Technologies – follow-on investment
We have recently made a follow-on investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund IV, the Parkwalk UK Tech Fund VII and the Parkwalk Opportunities Fund in a series ‘A’ financing round. Cambridge Touch Technologies… Read More
Healthera – University of Cambridge Enterprise Fund III investment
We are delighted to announce that the University of Cambridge Enterprise Fund III has invested in Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of… Read More
8Power – University of Cambridge Enterprise Fund III investment
We have recently made an investment in 8Power for the University of Cambridge Enterprise Fund III in a financing round. 8power Limited, a new company spun out of the University of Cambridge to develop and commercialise novel technology for… Read More
Parkwalk portfolio company CCMOSS – acquired by ams AG to become world leader in gas and infrared sensing
ams AG (SIX: AMS), a leading worldwide manufacturer of high performance sensor and analog solutions, has acquired 100% of the shares in Cambridge CMOS Sensors Ltd (CCS), the technology leader in micro hotplate structures for gas sensing and… Read More
Cambridge Touch Technologies – University of Cambridge Enterprise Fund III investment
We have recently made an investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund III in a seed financing round. Cambridge Touch Technologies (CTT), a University of Cambridge start-up poised to make 3D touch technology a standard… Read More
Sphere Fluidics – University of Cambridge Enterprise Fund III closes further funding round
We have closed an investment, in a $7m funding round, in Sphere Fluidics for the University of Cambridge Enterprise Fund III. This follows the UCEFs I and II investing previously. The investment round has been led by an Asian corporate investor Sphere Fluidics… Read More
Silicon Microgravity – University of Cambridge Enterprise Fund III investment
We have recently made an investment in Silicon Microgravity for the University of Cambridge Enterprise Fund III. Spun-out of the University of Cambridge Nanoscience Centre, Silicon Microgravity is commercializing a sensor technology which provides a breakthrough in the management… Read More
RoadMap – University of Cambridge Enterprise Fund III investment
We have recently made an investment in RoadMap for the University of Cambridge Enterprise Fund III in a Series ‘A’ financing. RoadMap is founded on four patents licensed from the Cambridge Centre for Advanced Photonics and Electronics (CAPE) in… Read More
Cytora – Parkwalk closes Investment for the University of Cambridge Enterprise Fund III
We are pleased to announce that the University of Cambridge Enterprise Fund III has closed an investment into Cytora, a geopolitical risk analytics spin-out from the University of Cambridge. Cytora is a pioneer in event detection, whose risk analytics… Read More
AQDOT – Follow on Investment
We have recently made a follow-on investment into Aqdot on behalf of the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III. Aqdot is a spin-out from the Department of Chemistry at the University of Cambridge and was… Read More
Parkwalk closes Quethera investment
We are pleased to announce that the University of Cambridge Enterprise Fund III has made an investment in Quethera, a gene therapy company spun-out of the University with a novel treatment for glaucoma. Quethera announces seed financing to develop… Read More
CCMOSS – Parkwalk closes further funding round
We have recently made an investment in Cambridge CMOS Sensors for the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III.. This follows predecessor funds investing in 2012 and 2013. Cambridge CMOS Sensors is a leading… Read More
Parkwalk closes Reduse investment
We are pleased to announce that the University of Cambridge Enterprise Fund III has made an investment in Reduse, a spin out from the Low Carbon Materials Processing Group at the University of Cambridge. Reduse are seeking to change… Read More
Parkwalk closes PhoreMost investment
We are pleased to announce that the University of Cambridge Enterprise Fund III has made an investment in PhoreMost as part of a £4m series ‘A’ round of equity and grant funding, of which the equity tranche was… Read More
